BridgeBio Pharma, Inc 10-K for FY2022
BridgeBio Pharma, Inc. (BBIO)
10-K
2023-02-23
For: 2022-12-31
View Original
Added on
April 08, 2026
About this 10-K
BridgeBio Pharma, Inc filed this 10-K on February 23, 2023, covering the fiscal year ended December 31, 2022 (FY2022).
Headline figures
Fiscal year ended December 31, 2022, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $77.65M
- up 11.4% from $69.72M a year earlier
- Net loss
- $484.65M
- compared with a net loss of $586.45M a year earlier
- Diluted EPS
- -$3.26
- compared with -$3.90 a year earlier